In the 'Supplements And Medications' section of our in-depth questionnaire we ask the following question about non-human estrogen use:
 |
 |
 |
|
Have you used non-human estrogens (such as Premarin, Estrace, or Prempro)? In the past, it may have been referred to as HRT (Hormone Replacement Therapy).
|
Your answer |
...indicates |
...and suggests |
| 1. |
"No / don't know" |
|
|
| 2. |
"For under 5 years, but not any more" |
Discontinued non-human estrogen use |
A risk factor |
| 3. |
"For 5 or more years, but not any more" |
Discontinued non-human estrogen use |
A risk factor |
| 4. |
"Current use for under 5 years" |
Non-human estrogen use |
A risk factor |
| 5. |
"Current use for 5 or more years" |
Non-human estrogen use |
A risk factor |
|
|
 |
|
 |
Your answer will affect the likelihoods of the conditions below.
Any answers in green reduce the likelihood of the condition.
|
|
|
|
| Answers |
Condition |
Comment |
|
|
3 |
4 |
5 |
Breast Cancer |
(Women only) Recent findings from a landmark study, published in The New England Journal of Medicine in 1995 and involving 121,700 women, revealed startling effects from non-human estrogen use. It warned that women who used this type of estrogens to offset the symptoms of menopause also increased their chance of developing breast cancer by 30-40% by taking the hormone for more than five years. In women aged between 60 and 64, the risk of breast cancer rose to 70% after five years of use. Finally, the study concluded that women were 45% more likely to die from breast cancer than those who chose not to use them or used them for less than five years. |
|
2 |
3 |
4 |
5 |
Endometrial Cancer |
(Women only) In 1975, The New England Journal of Medicine examined the rates of endometrial cancer for estrogen consumers, concluding that the risk was seven and a half times greater for estrogen users. Women who had used estrogen for seven years or longer were 14 times more likely to develop cancer. [Coney, Sandra, The Menopause Industry, Spinifex Press Pty Ltd., Australia, 1991, pp.164-5] |
|
2 |
3 |
4 |
5 |
Gallbladder Disease |
Taking non-human estrogens after menopause doubles the risk of gallbladder disease. |
|
|
3 |
4 |
5 |
Magnesium Requirement |
-- |
|
|
|
4 |
5 |
Progesterone Low or Estrogen Dominance |
(Women only) |
|
|
3 |
4 |
5 |
Vitamin B6 Requirement |
-- |
|
|
3 |
4 |
5 |
Zinc Requirement |
-- |
|
|
|
|
|
GLOSSARY
Cancer
Refers to the various types of malignant neoplasms that contain cells growing out of control and invading adjacent tissues, which may metastasize to distant tissues.
Estrogen (Oestrogen)
One of the female sex hormones produced by the ovaries.
Gallbladder (Gall Bladder)
A small, digestive organ positioned under the liver, which concentrates and stores bile. Problems with the gallbladder often lead to gallbladder attacks, which usually occur after a fatty meal and at night. The following are the most common symptoms: steady, severe pain in the middle-upper abdomen or below the ribs on the right; pain in the back between the shoulder blades; pain under the right shoulder; nausea; vomiting; fever; chills; jaundice; abdominal bloating; intolerance of fatty foods; belching or gas; indigestion.
Hormones (Hormone)
Chemical substances secreted by a variety of body organs that are carried by the bloodstream and usually influence cells some distance from the source of production. Hormones signal certain enzymes to perform their functions and, in this way, regulate such body functions as blood sugar levels, insulin levels, the menstrual cycle, and growth. These can be prescription, over-the-counter, synthetic or natural agents. Examples include adrenal hormones such as corticosteroids and aldosterone; glucagon, growth hormone, insulin, testosterone, estrogens, progestins, progesterone, DHEA, melatonin, and thyroid hormones such as thyroxine and calcitonin.
Menopause (Menopausal)
The cessation of menstruation (usually not official until 12 months have passed without periods), occurring at the average age of 52. As commonly used, the word denotes the time of a woman's life, usually between the ages of 45 and 54, when periods cease and any symptoms of low estrogen levels persist, including hot flashes, insomnia, anxiety, mood swings, loss of libido and vaginal dryness. When these early menopausal symptoms subside, a woman becomes postmenopausal.
Last updated: May 10, 2007
|
 |
|
|
